Search

Blog

We constantly analyse the legislation and regulatory information related to a specific medicine in order to appraise the context in which the company operates

We put all our knowledge into play to anticipate risks and seize every opportunity, but above all to understand the rules of the game and display our creativity with them. We spread material and information proceeding from our investigation into medicines governance and regulatory science. In fact, we deem it necessary to be aware of the complexity of the results of research, regulation and drug policy in order to be able to work in a cultural ecosystem aiming both at promoting research outcomes that are useful to patients and at encouraging politicians to protect people’s health. The wider the knowledge of each interest group, the greater their ability to interact and achieve transparency of procedures and health protection.

  • All
  • Scenario analysis
  • Notes
  • Drug Policy
  • Rare Diseases
  • Mapping
  • Team Pharma Value
All
  • All
  • Scenario analysis
  • Notes
  • Drug Policy
  • Rare Diseases
  • Mapping
  • Team Pharma Value

Summary of the WHO Guidelines on Drug Pricing Policies

Il 28 Settembre 2020 l’OMS ha pubblicato un documento dal titolo “WHO guideline on country pharmaceutical pricing policies”. Il documento sulle politiche ...
Read more "
Aifa Guidelines - Pharma Value comments

AIFA GUIDELINES - Our comments

Il 30 settembre 2020 abbiamo inviato all’indirizzo email dedicato di AIFA i nostri commenti alle “Linee guida per la compilazione del Dossier ...
Read more "

WE LIVE IN INTERESTING TIMES - MARKET ACCESS

Il contesto italiano del mercato farmaceutico, da quello normativo a quello regolatorio, è sempre stato uno scenario fortemente mutevole, sia per i ...
Read more "
LEA Commission

LEA Commission

È stata costituita con DM del 5/5/2020 la nuova Commissione nazionale per l’aggiornamento dei Livelli Essenziali di Assistenza (LEA). La commissione dura ...
Read more "

New technical table for oncohaematology and cardiology patients at the Ministry of Health

Su proposta di Fondazione Insieme contro il Cancro, nasce il Tavolo tecnico formato da oncologi, ematologi e cardiologi, per gestire le criticità ...
Read more "

Pandemic the game - why we win together

Sono un’amante dei giochi, da sempre. Mi piacciono i giochi di ruolo, di strategia, di abilità, i giochi con le carte, i ...
Read more "
COVID19 Technical Scientific Committee

COVID19 Technical Scientific Committee

Il Comitato Tecnico Scientifico COVID19 (CTS) a supporto del Governo è stato aggiornato il 18 aprile 2020 Chi sono i suoi componenti? ...
Read more "

Consiglio Superiore di Sanità - Non-authority appointed members

The Consiglio Superiore di Sanità is composed of thirty appointed members (by the Ministry of Health), also known as non-executive members, ...
Read more "

How to apply for and be reimbursed for a medicine by accessing the AIFA Fund 5% - Law 326

By Law 326/2003, a national fund was established, financed by 5% of the pharmaceutical companies' annual expenditure on ...
Read more "
en_GB